Proof of Usefulness Report

Asimov

Analysis completed on 3/23/2026

+520

Proof of Usefulness Score

Industry Mainstay

Asimov is a legitimate, highly innovative biotech company with a significant team size (350) and strong market relevance in synthetic biology. However, the submission itself appears to be from an unofficial or low-effort source, featuring exaggerated or inaccurate claims ('everyone', 'most people have used my product', nonsensical market cap figures) which heavily penalize the traction, reach, and response quality multipliers.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+225

Audience Reach Impact+50

Technical Innovation+135

Evidence Of Traction+50

Market Timing Relevance+85

Functional Completeness+2.5

Subtotal+547.5

Usefulness Multiplierx0.95

Final Score+520

Project Details

Project URL

asimov.com

Description

Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.

Algorithm Insights

Market Position

Strong market validation with clear user adoption patterns

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline